Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia

Annals of Neurology

Volumn 53, Issue 1, 2003, Pages 121-123

  Bunse, Michael ^a,b   Bit Avragim, Nana ^c   Riefflin, Axel ^d   Perrot, Andreas ^c   Schmidt, Oliver ^a,b   Kreuz, Friedmar R ^e   Dietz, Rainer ^c   Jung, Wulf Ingo ^a,b   Josef Osterziel, Karl ^c  

^a Hypertension/Diabet Research Unit   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d Dialysezentrum ^*  (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY BALANCE; ENERGY METABOLISM; FEMALE; FRIEDREICH ATAXIA; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; MITOCHONDRIAL ENERGY TRANSFER; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; CARDIOMEGALY; ENERGY METABOLISM; FEMALE; FRIEDREICH ATAXIA; HEART SEPTUM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHOCREATINE;

EID: 0037235890     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10419     Document Type: Article

References (8)

1. Puccio H, Simon D, Cossee M, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001;27:181-186.
2. Ristow M, Pfister M, Yee A, et al. Frataxin activates energy conversion and oxidative phosphorilation. Proc Natl Acad Sci USA 2000;97:112239-12243.
3. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-2542.
4. Bit-Avragim N, Perrot A, Schöls L, et al. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestations in patients with Friedreich's ataxia. J Mol Med 2001;78:626-632.
5. McKenna WJ, Spirito P, Desnos M, et al. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997;77:130-132.
6. 31P magnetic resonance spectroscopy study. Cardiovasc Res 2001;52:111-119.
7. 2 sub-unit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001;10:1215-1220.
8. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 1999;354:477-479.